Hankyel Park

Array ( [id] => 1411068 [patent_doc_number] => 06524853 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Vector expressing the full-length gene of RNA virus and use thereof' [patent_app_type] => B1 [patent_app_number] => 09/720201 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10100 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524853.pdf [firstpage_image] =>[orig_patent_app_number] => 09720201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6141530 [patent_doc_number] => 20020001798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-03 [patent_title] => 'Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof' [patent_app_type] => new [patent_app_number] => 09/740002 [patent_app_country] => US [patent_app_date] => 2000-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 20174 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20020001798.pdf [firstpage_image] =>[orig_patent_app_number] => 09740002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1410284 [patent_doc_number] => 06524809 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Analytical method using multiple virus labelling' [patent_app_type] => B1 [patent_app_number] => 09/701857 [patent_app_country] => US [patent_app_date] => 2000-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8355 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524809.pdf [firstpage_image] =>[orig_patent_app_number] => 09701857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1209147 [patent_doc_number] => 06713301 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens' [patent_app_type] => B1 [patent_app_number] => 09/701588 [patent_app_country] => US [patent_app_date] => 2000-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25010 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713301.pdf [firstpage_image] =>[orig_patent_app_number] => 09701588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1273277 [patent_doc_number] => 06649372 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-18 [patent_title] => 'Helper-free rescue of recombinant negative strand RNA virus' [patent_app_type] => B1 [patent_app_number] => 09/724412 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22985 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649372.pdf [firstpage_image] =>[orig_patent_app_number] => 09724412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1223492 [patent_doc_number] => 06699677 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-02 [patent_title] => 'Tethered ligands and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/721908 [patent_app_country] => US [patent_app_date] => 2000-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 25039 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699677.pdf [firstpage_image] =>[orig_patent_app_number] => 09721908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1353742 [patent_doc_number] => 06576467 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-10 [patent_title] => 'Methods for producing recombined antibodies' [patent_app_type] => B1 [patent_app_number] => 09/718764 [patent_app_country] => US [patent_app_date] => 2000-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 31629 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576467.pdf [firstpage_image] =>[orig_patent_app_number] => 09718764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1326457 [patent_doc_number] => 06602986 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'Methods for generating polynucleotides having desired characteristics by iterative selection and recombination' [patent_app_type] => B1 [patent_app_number] => 09/713920 [patent_app_country] => US [patent_app_date] => 2000-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 32600 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602986.pdf [firstpage_image] =>[orig_patent_app_number] => 09713920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1516939 [patent_doc_number] => 06500623 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Replication defective HIV vaccine' [patent_app_type] => B1 [patent_app_number] => 09/700304 [patent_app_country] => US [patent_app_date] => 2000-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 7798 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500623.pdf [firstpage_image] =>[orig_patent_app_number] => 09700304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1506829 [patent_doc_number] => 06440658 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Assay method for determining Product R\'s effect on adenovirus infection of Hela cells' [patent_app_type] => B1 [patent_app_number] => 09/705618 [patent_app_country] => US [patent_app_date] => 2000-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3845 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440658.pdf [firstpage_image] =>[orig_patent_app_number] => 09705618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1487463 [patent_doc_number] => 06428960 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Selection method for producing recombinant baculovirus' [patent_app_type] => B1 [patent_app_number] => 09/702181 [patent_app_country] => US [patent_app_date] => 2000-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9228 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/428/06428960.pdf [firstpage_image] =>[orig_patent_app_number] => 09702181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1595161 [patent_doc_number] => 06492165 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Retrovirus isolated from humans' [patent_app_type] => B1 [patent_app_number] => 09/692652 [patent_app_country] => US [patent_app_date] => 2000-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11983 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492165.pdf [firstpage_image] =>[orig_patent_app_number] => 09692652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1241084 [patent_doc_number] => 06682907 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-27 [patent_title] => 'Use of triplex structure DNA in transferring nucleotide sequences' [patent_app_type] => B1 [patent_app_number] => 09/688990 [patent_app_country] => US [patent_app_date] => 2000-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 36 [patent_no_of_words] => 15401 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/682/06682907.pdf [firstpage_image] =>[orig_patent_app_number] => 09688990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1577828 [patent_doc_number] => 06448078 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Cellular receptor for HIV-1 Vpr essential for G2/M phase transition of the cell cycle' [patent_app_type] => B1 [patent_app_number] => 09/529245 [patent_app_country] => US [patent_app_date] => 2000-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 13989 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448078.pdf [firstpage_image] =>[orig_patent_app_number] => 09529245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1423513 [patent_doc_number] => 06503733 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-07 [patent_title] => 'Human anion channel' [patent_app_type] => B1 [patent_app_number] => 09/690196 [patent_app_country] => US [patent_app_date] => 2000-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 18418 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/503/06503733.pdf [firstpage_image] =>[orig_patent_app_number] => 09690196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1600042 [patent_doc_number] => 06475792 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Methods for raising pre-adult anadromous fish' [patent_app_type] => B1 [patent_app_number] => 09/687476 [patent_app_country] => US [patent_app_date] => 2000-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 51 [patent_no_of_words] => 28611 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/475/06475792.pdf [firstpage_image] =>[orig_patent_app_number] => 09687476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1499903 [patent_doc_number] => 06485929 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-26 [patent_title] => 'Method for inhibiting CD95-independent apoptosis in AIDS' [patent_app_type] => B1 [patent_app_number] => 09/600522 [patent_app_country] => US [patent_app_date] => 2000-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 1685 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/485/06485929.pdf [firstpage_image] =>[orig_patent_app_number] => 09600522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440536 [patent_doc_number] => 06335017 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-01 [patent_title] => 'Compositions and methods for treating viral infections' [patent_app_type] => B1 [patent_app_number] => 09/677554 [patent_app_country] => US [patent_app_date] => 2000-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26647 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/335/06335017.pdf [firstpage_image] =>[orig_patent_app_number] => 09677554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1580883 [patent_doc_number] => 06423547 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-23 [patent_title] => 'Non-covalent bioconjugates useful for diagnosis and therapy' [patent_app_type] => B1 [patent_app_number] => 09/646765 [patent_app_country] => US [patent_app_date] => 2000-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4255 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/423/06423547.pdf [firstpage_image] =>[orig_patent_app_number] => 09646765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1527930 [patent_doc_number] => 06479284 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Humanized antibody and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/660169 [patent_app_country] => US [patent_app_date] => 2000-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 15514 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479284.pdf [firstpage_image] =>[orig_patent_app_number] => 09660169 [rel_patent_id] =>[rel_patent_doc_number] =>)